We then consolidated an OPN pathway and upregulated gene signatures from our findings (Spp1, Timp3, Col11a1, Mmp9, Mmp2, Fn1, Cd44, and Il-4) to interrogate how their predicted activity is associated with relapse-free survival in breast cancer patients. This evidence concerns the gene CD44 and breast cancer.